QuidelOrtho Corp

QDEL · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $0.8B · 6,500 employees
66
SEC Filings
$13.27
Close 2026-06-01
6,500
Employees

Business Summary

PartI All references to the Company, we, our and us in this Annual Report refer to QuidelOrtho Corporation (QuidelOrtho) and its subsidiaries. References to fiscal year ended 2025, fiscal year ended 2024 and fiscal year ended 2023 in this Annual Report refer to the Companys fiscal years ended December28, 2025, December29, 2024 and December31, 2023, respectively. Refer to the Summary of Abbreviated Terms at the end of this Annual Report for definitions of terms used throughout this Annual Report....

Latest Stock Quote

QDEL 2026-06-01 $13.27 O:$12.76 H:$13.29 L:$12.64 Vol:1.6M VWAP:$13.011
origin leaf: 02c6838c762be457c2c81de50f0a7b39d7d98becfcf93b285b35e9e7201245b1

Next Earnings

Q2 FY2026 — expected 2026-08-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-192025-12-280001906324-26-000008EDGAR80K words
2025-02-272024-12-290001906324-25-000035EDGAR
2024-02-292023-12-310001906324-24-000011EDGAR
2023-02-232023-01-010001906324-23-000014EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-280001906324-25-000160EDGAR23K words
2025-08-062025-06-290001906324-25-000151EDGAR
2025-05-082025-03-300001906324-25-000057EDGAR
2024-11-082024-09-290001906324-24-000049EDGAR
2024-08-012024-06-300001906324-24-000045EDGAR
2024-05-092024-03-310001906324-24-000032EDGAR
2023-11-022023-10-010001906324-23-000058EDGAR
2023-08-092023-07-020001906324-23-000046EDGAR
2023-05-042023-04-020001906324-23-000033EDGAR
2022-11-042022-10-020001906324-22-000033EDGAR
2022-08-052022-07-030001906324-22-000011EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001193125-26-120684EDGAR1K words
2026-02-130001193125-26-051461EDGAR
2026-02-110001906324-26-000003EDGAR
2026-02-050001193125-26-039440EDGAR
2025-11-100001193125-25-273317EDGAR
2025-11-050001906324-25-000158EDGAR
2025-08-210001193125-25-185355EDGAR
2025-08-050001906324-25-000150EDGAR
2025-05-270001193125-25-127604EDGAR
2025-05-070001906324-25-000055EDGAR

66 total filings indexed. 41 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE

Company Identity

CIK0001906324
TickerQDEL
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
Websitehttps://www.quidelortho.com
Listed1981-08-04

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 81a5e35310622f6273bea802cdc194ff1bf425f4f7448e12f795205b719c0adb
parent: 3653e407968ea5a71549f386721ca9697d58fc2b4cd0e6c2f9868a64d89853ed
content hash: efc1652fadef8e61d8a639c679949f53907c884266318817ee1d4812c6080a0a
signed: 2026-06-02T19:02:23.928Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf